Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Onco-Innovations Ltd. ( (TSE:ONCO) ).
Onco-Innovations Ltd. has announced an Expression of Interest between its subsidiary, Inka Health, and Quantify Research to explore collaborations in healthcare data analytics, focusing on oncology research. This partnership aims to advance the development of Inka’s SynoGraph™ platform by utilizing Quantify’s expertise in real-world data analytics and AI-powered predictive modeling, potentially enhancing precision medicine and improving cancer treatment strategies.
More about Onco-Innovations Ltd.
Onco-Innovations Ltd. operates in the healthcare industry, focusing on oncology research and drug development. Through its subsidiary Inka Health Corp., it specializes in leveraging AI-driven predictive modeling to enhance cancer treatment insights and precision medicine approaches.
YTD Price Performance: 152.94%
Average Trading Volume: 400,902
For an in-depth examination of ONCO stock, go to TipRanks’ Stock Analysis page.
